Kidney Cancer
-
ASCO
Kidney Cancer Research Highlights from ASCO 2022 Annual Meeting
. Updated Yasser Ged,1 and Nirmish Singla2,* 1) Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA…
Read More » -
Kidney Cancer
Comparison of Papillary Renal Cell Carcinoma Type 1 and Type 2: A Secondary Data Analysis
Melissa Paquin, PhD,1 Tracy Fasolino, PhD, FNP,2 Joe Bible, PhD,3 Mary Beth Steck, PhD,2 Joel Williams, PhD.4 1. Clemson University, Hampton, GA 30228 USA.…
Read More » -
GU CANCERS
Recent Advances in Tivozanib plus Nivolumab Combinatorial Strategies in Renal Cell Carcinoma
Robert J Motzer, MD 1, Toni K Choueiri, MD 2, Laurence Albiges, MD, PhD 3,Robert A. Figlin, MD, FACP4 Memorial…
Read More » -
Cancer
MEDICAL INTELLIGENCE – Kidney Cancer
Newsworthy, late-breaking kidney cancer information from Web-based sources, professional societies, and government agencies FDA Approves Tivozanib as First Therapy for…
Read More » -
Kidney Cancer
Guidelines for Kidney Cancer Treatment
A list of global guidelines for kidney cancer are provided in this section. These guidelines provide evidence-based recommendations to serve as a guide…
Read More »
